Market report
Dermatological drug tenders in Czechia — market report, August 2025
Dermatological drug tenders in Czechia in August 2025: 5,988 tenders published (-12% month on month, +4% year on year), estimated at €97,682 in total, and 6,004 contracts awarded (-12% month on month, +4% year on year), worth €4,347,195 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (1,895), Krajská zdravotní, a.s. (676) and Fakultní nemocnice Bulovka (606); most contracts won: ROCHE s.r.o. (184), ViaPharma s.r.o. (151) and Amgen s.r.o. (100). On average 1.8 bids per contract; 40% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 5,988
- Contracts awarded
- 6,004
- Contract value awarded
- €4,347,195
- Bids per contract
- 1.8
The highlighted bar is August 2025. Hover a bar for its figure; the table below has every value.
| Figure | August 2025 | July 2025 | Change | August 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 5,988 | 6,801 | -12% | 5,777 | +4% |
| Estimated value | €97,682 | €779,439 | -87% | €5,618,006 | -98% |
| Buyers | 30 | 27 | +11% | 35 | -14% |
| Contracts awarded | 6,004 | 6,810 | -12% | 5,776 | +4% |
| Contract value (awarded) | €4,347,195 | €4,302,647 | +1% | — | — |
| Winners | 264 | 246 | +7% | 273 | -3% |
| Bids per contract | 1.8 | 1.5 | — | 3.1 | — |
| Single-bid contracts | 40% | 50% | — | 14% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ROCHE s.r.o. | 184 |
| 2 | ViaPharma s.r.o. | 151 |
| 3 | Amgen s.r.o. | 100 |
| 4 | AbbVie s.r.o. | 94 |
| 5 | Janssen-Cilag s.r.o. | 90 |
| 6 | Takeda Pharmaceuticals Czech Republic s.r.o. | 77 |
| 7 | Avenier a.s. | 67 |
| 8 | BAYER s.r.o. | 64 |
| 9 | Merck Sharp & Dohme s.r.o. | 59 |
| 10 | Gilead Sciences s.r.o. | 58 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in August 2025?
- 5,988 (by 30 buyers); for comparison, July 2025: 6,801, August 2024: 5,777.
- Who won the most dermatological drug tenders in Czechia in August 2025?
- By number of contracts: ROCHE s.r.o. (184), ViaPharma s.r.o. (151), Amgen s.r.o. (100), AbbVie s.r.o. (94) and Janssen-Cilag s.r.o. (90); 264 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in August 2025?
- Krajská nemocnice T. Bati, a. s. (1,895), Krajská zdravotní, a.s. (676), Fakultní nemocnice Bulovka (606), Fakultní nemocnice Brno (422) and Nemocnice České Budějovice, a.s. (269).
- How competitive were dermatological drug tenders in Czechia in August 2025?
- On average 1.8 bids per contract (15 contracts with a known number of bids); 40% of contracts had a single bid.
- What were the contracts worth in August 2025?
- €4,347,195 (awarded value, 6,004 contracts); median about €230,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.